SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-321531
Filing Date
2020-12-18
Accepted
2020-12-18 16:30:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d206768d424b5.htm 424B5 368224
2 GRAPHIC g206768g71p99.jpg GRAPHIC 50472
  Complete submission text file 0001193125-20-321531.txt   438897
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-249881 | Film No.: 201400992
SIC: 2836 Biological Products, (No Diagnostic Substances)